Latest stories

  • in

    Ease arthritis pain with weight loss: 4 exercises that can help

    Women with arthritis would know that one or more joints take a hit. There is inflammation or swelling. The symptoms vary as there are different types of arthritis, but there is joint pain as well as stiffness. According to the US Centers for Disease Control and Prevention, weight loss can ease arthritis pain and also […] More

  • in

    Decoding Safety and Efficacy of Generic Tofacitinib Tablets in Rheumatoid Arthritis: Indian Evidence

    Decoding Safety and Efficacy of Generic Tofacitinib Tablets in Rheumatoid Arthritis: Indian Evidence

    Rheumatoid Arthritis (RA) is one of the most debilitating chronic autoimmune affecting joints leading to inflammation, pain, persistent synovitis, and eventual joint destruction. RA primarily affects small joints and may have extra-articular involvement in organs such as the lungs, heart etc. Prima facie, this disease causes severe disability, decreased quality of life and life expectancy. […] More

  • in

    Late-onset Psoriatic Arthritis linked to increased cardiovascular risk

    Late-onset Psoriatic Arthritis linked to increased cardiovascular risk

    Greece: According to a recent study published in Life (Basel) Journal, psoriatic arthritis (PsA) is becoming increasingly common in older people and is associated with an elevated cardiovascular risk. The study aimed to explore whether late-onset PsA patients, diagnosed at 60 years of age or older, displayed different clinical features, treatment approaches, and comorbidity profiles […] More

  • in

    Shilpa Medicare Psoriatic arthritis drug Apremilast gets USFDA okay

    Shilpa Medicare Psoriatic arthritis drug Apremilast gets USFDA okay

    Karnataka: Shilpa Medicare has recently announced that the Company has received final approval from the U.S Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA), Apremilast Tablets, 10 mg, 20 mg, and 30 mg. The medicine is indicated for the treatment of adult patients with active psoriatic arthritis. Psoriatic arthritis is a long-term inflammatory arthritis. It occurs in individuals […] More

  • in

    COVID-19 can act as trigger for development of reactive arthritis

    Germany: A recent review has stated that coronavirus disease-19 (COVID-19) could target the musculoskeletal system leading to reactive arthritis in the post-infectious stage; however, the evidence the poor. The research was featured in the Journal of Orthopaedic Surgery and Research on 15 March 2023. The investigators found that COVID-19 can act as a trigger or […] More